CFGS
BIIB icon

Concourse Financial Group Securities’s Biogen BIIB Stock Holding History

Concourse Financial Group Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$999 – 214
2024
Q4 		$999 Hold
7
– – ﹤0.01% 2100
2024
Q3 		$1.36K Sell
7
-15
-68% -$3.14K ﹤0.01% 2030
2024
Q2 		$5.1K Sell
22
-3
-12% -$652 ﹤0.01% 1865
2024
Q1 		$5.39K Sell
25
-41
-62% -$9.6K ﹤0.01% 1862
2023
Q4 		$17.1K Sell
66
-6
-8% -$1.47K ﹤0.01% 1535
2023
Q3 		$18.5K Buy
72
+42
+140% +$11.2K ﹤0.01% 1463
2023
Q2 		$8.54K Buy
30
+3
+11% +$893 ﹤0.01% 1698
2023
Q1 		$7.51K Buy
27
+5
+23% +$1.38K ﹤0.01% 1745
2022
Q4 		$6.09K Buy
22
+7
+47% +$1.98K ﹤0.01% 1801
2022
Q3 		$4K Hold
15
– – ﹤0.01% 1665
2022
Q2 		$3K Hold
15
– – ﹤0.01% 1945
2022
Q1 		$3K Sell
15
-57
-79% -$12.4K ﹤0.01% 1942
2021
Q4 		$17K Sell
72
-100
-58% -$25.7K ﹤0.01% 1694
2021
Q3 		$49K Buy
172
+100
+139% +$32.8K ﹤0.01% 1315
2021
Q2 		$25K Sell
72
-124
-63% -$37.6K ﹤0.01% 1568
2021
Q1 		$55K Buy
196
+51
+35% +$13.8K ﹤0.01% 1186
2020
Q4 		$36K Sell
145
-2
-1% -$516 ﹤0.01% 1244
2020
Q3 		$42K Sell
147
-117
-44% -$32.6K ﹤0.01% 1122
2020
Q2 		$71K Sell
264
-21
-7% -$6.31K 0.01% 841
2020
Q1 		$90K Sell
285
-24
-8% -$7.28K 0.01% 695
2019
Q4 		$92K Buy
309
+118
+62% +$32.7K 0.01% 737
2019
Q3 		$44K Sell
191
-331
-63% -$77.1K 0.01% 662
2019
Q2 		$122K Buy
522
+270
+107% +$62.3K 0.01% 612
2019
Q1 		$59K Buy
252
+109
+76% +$34.3K 0.01% 818
2018
Q4 		$43K Buy
143
+45
+46% +$14.4K 0.01% 862
2018
Q3 		$35K Buy
+98
New +$33.7K 0.01% 669

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Concourse Financial Group Securities's BIIB Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Biogen (BIIB) in Q1 2025, closing a stake of 7 shares — an estimated $999 sold.

Concourse Financial Group Securities first reported a position in BIIB in Q3 2018 and held it in 26 quarters. The position peaked at $122K in Q2 2019. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 7 Biogen shares in Q1 2025, an estimated $999.
  • Concourse Financial Group Securities first reported a position in Biogen in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Biogen position peaked at $122K in Q2 2019.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.